ESC Congress 2026

At Roche, we have made it our mission to lead a paradigm shift: moving care from fragmented, late-stage interventions to proactive, integrated, and continuous disease management that puts us ahead of care. We are doing this by building interconnected "Solution Ecosystems" that combine AI-enabled digital algorithms, point-of-care decentralized testing and highly accurate lab tests.

We aim to deliver holistic care for people living with cardiometabolic conditions - from diagnosis to treatment to on-going monitoring. Our goal is to enable excellence in patient-centric decision-making and help tackle the high burden of Cardiometabolic diseases in our society.

This event is a premier opportunity to explore the forefront of medical innovation. The immersive experience at our booth will inspire you to learn about:

1. Advancing CVRM drug development
2. Engaging in clinical dialogue with scientific leaders
3. Our cardiometabolic portfolio: At the forefront of disease management

• The Roche ACS Ecosystem - Discover our latest innovations: Elecsys® Troponin T hs Gen 6, setting a new benchmark for high-sensitivity testing, and the upcoming cobas® sense platform—engineered to bring lab-like performance¹ right to the point of care with results fully standardized to our core lab assay.
• Cardiovascular Risk Ecosystem - Roche supports the measurement of cardiovascular risk markers at various levels of clinical evidence to support comprehensive ASCVD management.^2,3 Our Lp(a) and hsCRP assays empower clinicians by providing the actionable data necessary for targeted cardiovascular risk stratification. 
• Heart Failure Ecosystem - Roche has pioneered NT-proBNP for central labs and the point of care, to support early HF diagnosis.^4-8 We support clinical decision making at every stage of care in heart failure, with assays that can help provide diagnostic confidence. Empowering heart failure decisions with diagnostic solutions tailored for diverse clinical settings.
• Advancing CV Therapeutics - Join the Roche Pharma team to learn more about our CV pipeline, focused on addressing the most pressing unmet needs in cardiovascular care.